Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ImmunoVec
AddedFeb 17, 2024
UpdatedJun 18, 2026
ImmunoVec

ImmunoVec

Series A

Santa Monica-based ImmunoVec develops gene therapy treatments for terminal immune system diseases.

HQ
Santa Monica, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded in Santa Monica, California, ImmunoVec is dedicated to developing gene therapy treatments aimed at curing terminal genetic diseases of the immune system. The company's core mission is to provide life-saving therapies for hematopoietic diseases, leveraging advanced genetic engineering techniques to address conditions that currently have limited treatment options. ImmunoVec's vision is to revolutionize the field of gene therapy and offer hope to patients with otherwise incurable immune system disorders.

Notable figures associated with ImmunoVec include leading scientists and researchers in the field of gene therapy. The company has attracted significant attention from investors interested in cutting-edge medical technologies. Key achievements include successful preclinical trials demonstrating the efficacy of their gene therapy solutions. ImmunoVec's impact lies in its potential to transform the treatment landscape for severe immune system diseases, offering new possibilities for patients and advancing the field of genetic medicine.

ImmunoVec - Similar Companies

Inimmune logo

Inimmune

inimmune.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Immusoft logo

Immusoft

immusoft.com

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

ImmuneTarget logo

ImmuneTarget

ImmunGene logo

ImmunGene

ImmuneBridge logo

ImmuneBridge

immunebridge.com

Jaguar Gene Therapy logo

Jaguar Gene Therapy

Locanabio logo

Locanabio

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Immunome logo

Immunome

Cancervax logo

Cancervax

cancervax.com

Rampart Bioscience logo

Rampart Bioscience

rampartbio.com

Excision BioTherapeutics logo

Excision BioTherapeutics

Immpact Bio logo

Immpact Bio

immpact-bio.com

ImmunoVec - Quick Facts

Who are ImmunoVec's competitors?

Companies similar to ImmunoVec include Inimmune, ImmunoGenesis, Immusoft and Immunitas Therapeutics.

When was ImmunoVec founded?

ImmunoVec was founded in 2019.

Where is ImmunoVec's headquarters located?

ImmunoVec's headquarters is located in Santa Monica, CA, US.

When was ImmunoVec's last funding round?

ImmunoVec's most recent funding round was for $4.3M (USD) in March 2022.

How much has ImmunoVec raised to-date?

As of Mar 1, 2022, ImmunoVec has raised a total of $4.3M (USD).

How many employees does ImmunoVec have?

ImmunoVec has 6 employees as of Feb 5, 2024.

ImmunoVec - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Main Product
  • Gene Therapy
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research